Target Validation Information
Target ID T77365
Target Name Adenosine A2a receptor
Target Type
Successful
Drug Potency against Target ALLOXAZINE Drug Info Ki = 935 nM [527823]
METHYLTHIOADENOSINE Drug Info Ki = 1180 nM [527040]
8-Bromo-9-(2-hydroxypropyl)-9H-adenine Drug Info Ki = 1100 nM [530014]
9-BENZYL-9H-ADENINE Drug Info Ki = 8500 nM [530014]
LUF-5957 Drug Info Ki = 118 nM [528192]
2-(3''-(5''-methoxy-indolyl)ethyloxy)adenosine Drug Info Ki = 1400 nM [528748]
9-(sec-Butyl)-9H-adenine Drug Info Ki = 16000 nM [530014]
N6-methoxy-2-[2-(trimethylsilyl)ethynyl]adenosine Drug Info Ki = 5740 nM [528684]
2,6-diphenyl-8-tButyl-1-deazapurine Drug Info Ki = 1055 nM [528673]
LUF-5980 Drug Info Ki = 230 nM [528673]
2,5'-dichloro-5'-deoxy-N6-cyclopentyladenosine Drug Info Ki = 2160 nM [530035]
LUF-5956 Drug Info Ki = 148 nM [528192]
N-(2,6-diphenylpyrimidin-4-yl)isobutyramide Drug Info Ki = 376 nM [527331]
2-(4-ethylthiobenzimidazol-2-yl)quinoxaline Drug Info Ki = 3440 nM [527933]
Tonapofylline Drug Info Ki = 2440 nM [530752]
2-(3''-pyrrolylethyloxy)adenosine Drug Info Ki = 95 nM [528748]
2-(3''(7''-bromo-indolyl)ethyloxy)adenosine Drug Info Ki = 252 nM [528748]
2-(3''-(5''-fluoro-indolyl)ethyloxy)adenosine Drug Info Ki = 370 nM [528748]
2-(3''(5''-chloro-indolyl)ethyloxy)adenosine Drug Info Ki = 390 nM [528748]
2-(3''-(4''-bromo-indolyl)ethyloxy)adenosine Drug Info Ki = 39.7 nM [528748]
2-ethynyl-N6-methoxyadenosine Drug Info Ki = 3140 nM [528684]
2-(3''-indolylethyloxy)adenosine Drug Info Ki = 45 nM [528748]
N6-methoxy-2-[(4-pentylphenyl)ethynyl]adenosine Drug Info Ki = 6520 nM [528684]
2-(hex-1-ynyl)-N6-methoxyadenosine Drug Info Ki = 267 nM [528684]
2-[(4-fluorophenyl)ethynyl]-N6-methoxyadenosine Drug Info Ki = 3960 nM [528684]
2-ethyl-4-(furan-2-yl)thieno[3,2-d]pyrimidine Drug Info Ki = 30 nM [529419]
2-(2''-indolylethyloxy)adenosine Drug Info Ki = 373 nM [528748]
N-(2,6-diphenylpyrimidin-4-yl)-3-methylbutyramide Drug Info Ki = 157 nM [527331]
2-(1H-benzo[d]imidazol-2-yl)quinoxaline Drug Info Ki = 561 nM [529313]
2-(3''-(6''-chloro-indolyl)ethyloxy)adenosine Drug Info Ki = 29.3 nM [528748]
N6-methoxy-2-[(3-pyridinyl)ethynyl]-adenosine Drug Info Ki = 12500 nM [528684]
2-(4-methyl-1H-benzo[d]imidazol-2-yl)quinoxaline Drug Info Ki = 833 nM [529313]
Cyclohexyl-(2-phenoxy-9H-purin-6-yl)-amine Drug Info Ki = 16000 nM [527647]
KW-6002 Drug Info Ki = 13 nM [552327]
2-Amino-6-furan-2-yl-4-phenyl-nicotinonitrile Drug Info Ki = 11 nM [529602]
2-ethyl-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine Drug Info Ki = 69 nM [529419]
1-Ethyl-3-methyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 5000 nM [533486]
1-Allyl-3,7-dimethyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 6500 nM [533486]
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one Drug Info Ki < 1000 nM [531079]
8-Phenyl-1-propyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 1900 nM [526958]
N-(2-(furan-2-yl)-3,4'-bipyridin-6-yl)acetamide Drug Info Ki = 209 nM [530694]
4-(ethylthio)-6-phenyl-1,3,5-triazin-2-amine Drug Info Ki = 5 nM [528434]
PSB-0788 Drug Info Ki = 1730 nM [530243]
2-(4-chlorophenyl)-6-phenyl-9H-purine Drug Info Ki = 315 nM [528192]
N-(2,6-diphenylpyrimidin-4-yl)butyramide Drug Info Ki = 124 nM [527331]
FK-838 Drug Info Ki = 1202 nM [530752]
2-tolyl-6-phenyl-9H-purine Drug Info Ki = 289 nM [528192]
N-(4,6-diphenylpyrimidin-2-yl)propionamide Drug Info Ki = 893 nM [527331]
PSB-601 Drug Info Ki = 93.7 nM [530243]
GNF-PF-2700 Drug Info Ki = 624 nM [530966]
9-But-3-enyl-9H-adenine Drug Info Ki = 8500 nM [530014]
2,6,8-triphenyl-9H-purine Drug Info Ki = 66 nM [528192]
9-Methyl-9H-adenine Drug Info Ki = 6900 nM [530014]
9-Cyclobutyl-9H-adenine Drug Info Ki = 4800 nM [530014]
8-Bromo-9-phenylethyl-9H-adenine Drug Info Ki = 4900 nM [530014]
8-Br-adenine Drug Info Ki = 3200 nM [530014]
8-Bromo-9-cyclopentyl-9H-adenine Drug Info Ki = 1900 nM [530014]
2-(5-cyano-1-pent-1-ynyl)-N6-methoxyadenosine Drug Info Ki = 1820 nM [528684]
2-(3''-(6''-bromo-indolyl)ethyloxy)adenosine Drug Info Ki = 150 nM [528748]
4-Amino-2,6-diphenyl-pyrimidine-5-carbonitrile Drug Info Ki = 19 nM [529299]
9-Cyclopropyl-9H-adenine Drug Info Ki = 2300 nM [530014]
9-Benzyl-8-bromo-9H-adenine Drug Info Ki = 6100 nM [530014]
2-Amino-4,6-diphenyl-pyrimidin-5-carbonitrile Drug Info Ki = 22.7 nM [529299]
2-(3''-(5''-iodo-indolyl)ethyloxy)adenosine Drug Info Ki = 900 nM [528748]
8-Bromo-9-(3-hydroxypropyl)-9H-adenine Drug Info Ki = 85 nM [530014]
2,6-diphenyl-1-deazapurine Drug Info Ki = 39 nM [528673]
N6-methoxy-2-[(4-methoxyphenyl)ethynyl]adenosine Drug Info Ki = 1780 nM [528684]
LUF-5978 Drug Info Ki = 189 nM [528673]
8-bromo-9-isobutyl-9H-purin-6-amine Drug Info Ki = 6000 nM [530966]
2,6-diphenyl-8-(1-ethylpropyl)-1-deazapurine Drug Info Ki = 247 nM [528673]
5,7-dibromo-9H-pyrido[3,4-b]indol-6-ol Drug Info Ki = 4920 nM [529305]
9-Butyl-9H-adenine Drug Info Ki = 7800 nM [530014]
N-(2,6-diphenylpyrimidin-4-yl)acetamide Drug Info Ki = 489 nM [527331]
9-benzyl-6-(furan-2-yl)-9H-purin-2-amine Drug Info Ki = 40 nM [529421]
1-METHYLXANTHINE Drug Info Ki = 6600 nM [533429]
1,3-Diallyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 820 nM [533429]
2-Amino-4,6-di-thiophen-2-yl-nicotinonitrile Drug Info Ki = 32 nM [529602]
9-(2-Hydroxypropyl)-9H-adenine Drug Info Ki = 3100 nM [530014]
N-(2,6-diphenylpyrimidin-4-yl)propionamide Drug Info Ki = 81.9 nM [527331]
1,3-Diethyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 1200 nM [533429]
8-propyl-2,6-diphenyl-9H-purine Drug Info Ki = 167 nM [528192]
N6-methoxy-2-[(4-pyridinyl)ethynyl]adenosine Drug Info Ki = 6310 nM [528684]
2-(3''-(5''-bromo-indolyl)ethyloxy)adenosine Drug Info Ki = 502 nM [528748]
2-Amino-4-furan-2-yl-6-phenyl-nicotinonitrile Drug Info Ki = 19 nM [529602]
9-Ethyl-8-phenylethynyl-9H-purin-6-ylamine Drug Info Ki = 600 nM [526104]
METRIFUDIL Drug Info Ki = 25 nM [525578]
2-m-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine Drug Info Ki = 228 nM [528969]
GW-328267 Drug Info IC50 = 0.4 nM [530595]
2-(4-hydroxypent-1-yl)-N6-methoxyadenosine Drug Info Ki = 758 nM [528684]
2-phenyl-2H-pyrazolo[3,4-c]quinolin-4-amine Drug Info Ki = 91 nM [528969]
2-ethyl-4-(furan-3-yl)thieno[3,2-d]pyrimidine Drug Info Ki = 681 nM [529419]
N6-CYCLOPENTYLADENOSINE Drug Info Ki = 2470 nM [530752]
N6-methoxy-2-phenylethynyladenosine Drug Info Ki = 4290 nM [528684]
2-p-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine Drug Info Ki = 329 nM [528969]
R-N6-(phenylisopropyl)adenosine Drug Info Ki = 884 nM [528748]
LUF-5767 Drug Info Ki = 899 nM [527331]
2-chloro-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine Drug Info Ki = 391 nM [529419]
2-Amino-6-phenyl-4-thiophen-2-yl-nicotinonitrile Drug Info Ki = 54 nM [529602]
2-chloro-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine Drug Info Ki = 20 nM [529419]
KF-17837 Drug Info Ki = 1 nM [533955]
2-Phenyl-1H-imidazo[4,5-c]quinolin-4-ylamine Drug Info Ki = 290 nM [530590]
N6-methoxy-2-[(2-pyridinyl)ethynyl]adenosine Drug Info Ki = 2960 nM [528684]
2-amino-N-benzyl-6-phenyl-9H-purine-9-carboxamide Drug Info Ki = 17 nM [529421]
2-Cyclopentyl-1H-imidazo[4,5-c]quinolin-4-ylamine Drug Info Ki = 740 nM [530590]
N*6*-Cyclohexyl-N*2*-phenyl-9H-purine-2,6-diamine Drug Info Ki = 1700 nM [527647]
4-(furan-2-yl)thieno[3,2-d]pyrimidin-2-amine Drug Info Ki = 14 nM [529421]
6-Furan-2-yl-9-phenyl-9H-purin-2-ylamine Drug Info Ki = 68.5 nM [527503]
BG-9928 Drug Info Ki = 29 nM [528068]
Kuanoniamine D Drug Info Ki = 13700 nM [534583]
PD-115199 Drug Info Ki = 15.5 nM [527717]
7-Propyl-7H-adenine Drug Info Ki = 18000 nM [530014]
4-(thiazol-2-yl)thieno[3,2-d]pyrimidin-2-amine Drug Info Ki = 35 nM [529419]
(Z)-8-(3-chlorostyryl)caffeine Drug Info Ki = 30.2 nM [529653]
FR-166124 Drug Info IC50 = 6200 nM [525562]
N6-(4-hydroxybenzyl)adenine riboside Drug Info Ki = 2620 nM [528752]
9-Methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine Drug Info Ki = 46.3 nM [527823]
2,6-diphenyl-8-methyl-1-deazapurine Drug Info Ki = 375 nM [528673]
2,6-diphenyl-8-ethyl-1-deazapurine Drug Info Ki = 177 nM [528673]
SB-298 Drug Info Ki = 2139 nM [530243]
(E,E)-8-[4-(3-Chlorophenyl)butadien-1-yl]caffeine Drug Info Ki = 104 nM [529653]
3-noradamantyl-1,3-dipropylxanthine Drug Info Ki = 673 nM [528544]
PSB-09120 Drug Info Ki = 122 nM [530243]
9-Allyl-8-bromo-9H-adenine Drug Info Ki = 730 nM [530014]
5-Butyl-8-phenyl-3H-[1,2,4]triazolo[5,1-i]purine Drug Info IC50 = 71 nM [527055]
7-Isopropyl-7H-adenine Drug Info Ki = 12000 nM [530014]
8-Bromo-9-(but-3-enyl)-9H-adenine Drug Info Ki = 1600 nM [530014]
9-Propyl-9H-adenine Drug Info Ki = 9600 nM [530014]
8-Bromo-9-isopropyl-9H-adenine Drug Info Ki = 74 nM [530014]
8-Bromo-9-cyclohexyl-9H-adenine Drug Info Ki = 15000 nM [530014]
9-Ethyl-9H-adenine Drug Info Ki = 2200 nM [530014]
OSIP-339391 Drug Info Ki = 328 nM [530966]
8-Bromo-9-propyl-9H-adenine Drug Info Ki = 300 nM [530014]
8-PHENYL THEOPHYLLINE Drug Info Ki = 850 nM [530590]
ST-1535 Drug Info Ki = 6.6 nM [529602]
1-Butyl-8-phenyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 642 nM [526958]
1,3-Dipropyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 680 nM [533429]
5,7-diphenyl-3H-imidazo[4,5-b]pyridin-2-ol Drug Info Ki = 192 nM [528673]
ISOGUANOSINE Drug Info Ki = 331 nM
KW-6002 Drug Info Ki = 2 nM [529255]
8-Bromo-9-cyclobutyl-9H-adenine Drug Info Ki = 660 nM [530014]
9-Cycloheptyl-9H-adenine Drug Info Ki = 11000 nM [530014]
9-Phenylethyl-9H-adenine Drug Info Ki = 9600 nM [530014]
(S)-DHPA Drug Info Ki = 8500 nM [530014]
8-Bromo-9-ethyl-9H-adenine Drug Info Ki = 52 nM [530014]
LUF-5981 Drug Info Ki = 194 nM [528673]
8-Bromo-9-(sec-butyl)-9H-adenine Drug Info Ki = 390 nM [530014]
8-Bromo-9-(2,3-dihydroxypropyl)-9H-adenine Drug Info Ki = 4000 nM [530014]
(E,E)-8-[4-(3-Fluorophenyl)butadien-1-yl]caffeine Drug Info Ki = 114 nM [529653]
2,6-Diphenyl-pyrimidin-4-ylamine Drug Info Ki = 169 nM [529299]
2-phenylpropoxyadenosine Drug Info Ki = 500 nM [528748]
6-guanidino-2-(3''-indolylethyloxy)adenosine Drug Info Ki = 277 nM [528748]
8-Bromo-9-methyl-9H-adenine Drug Info Ki = 120 nM [530014]
2-(3''-(benzoimidazole-1''-yl)ethyloxy)adenosine Drug Info Ki = 3870 nM [528748]
2-[(4-acetylphenyl)ethynyl]-N6-methoxyadenosine Drug Info Ki = 2680 nM [528684]
2,6-diphenyl-9H-purine Drug Info Ki = 53 nM [528192]
9-(3-Hydroxypropyl)-9H-adenine Drug Info Ki = 3900 nM [530014]
9-(2-Hydroxyethyl)-9H-adenine Drug Info Ki = 11000 nM [530014]
(E,E)-8-[4-(3-Bromophenyl)butadien-1-yl]caffeine Drug Info Ki = 59.1 nM [529653]
N-(2,6-diphenylpyrimidin-4-yl)-2-ethylbutyramide Drug Info Ki = 381 nM [527331]
3-Isopropyl-1-methyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 6000 nM [533486]
8-Bromo-9-(2-butyl)-9H-adenine Drug Info Ki = 730 nM [530014]
1,3-Diallyl-7-methyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 4000 nM [533486]
2-amino-6-phenyl-4-p-tolylnicotinonitrile Drug Info Ki = 118 nM [528434]
9-(3-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine Drug Info Ki = 85 nM [529421]
3-Isobutyl-1-methyl-3,9-dihydro-purine-2,6-dione Drug Info Ki = 8000 nM [533486]
2-ethyl-4-(pyridin-2-yl)thieno[3,2-d]pyrimidine Drug Info Ki = 13 nM [529419]
FK-453 Drug Info IC50 = 1180 nM [530752]
2-(3''-(5''-hydroxyindolyl)ethyloxy)adenosine Drug Info Ki = 450 nM [528748]
2-Amino-4-phenyl-6-thiophen-2-yl-nicotinonitrile Drug Info Ki = 88 nM [529602]
N6-[(4-Nitro)-phenyl]-9-benzyl-2-phenyladenine Drug Info Ki = 1900 nM [529183]
1,3,7-Tripropyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 1400 nM [533486]
2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine Drug Info Ki = 1.6 nM [529419]
2-Amino-4,6-di-furan-2-yl-nicotinonitrile Drug Info Ki = 1 nM [529602]
7-Allyl-1,3-dimethyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 10000 nM [533486]
7-Allyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 700 nM [533486]
1,3-Diisobutyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 1700 nM [533486]
9-(3-aminobenzyl)-6-(furan-2-yl)-9H-purin-2-amine Drug Info Ki = 23 nM [529421]
Cyclohexyl-(2-phenylsulfanyl-9H-purin-6-yl)-amine Drug Info Ki = 14000 nM [527647]
1,3,8-Trimethyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 14000 nM [533394]
ZM-241385 Drug Info Ki = 1.2 nM [530372]
LUF-5433 Drug Info Ki = 1900 nM [530752]
N-(5-Benzoyl-4-phenylthiazol-2-yl)benzamide Drug Info Ki = 3030 nM [530752]
LUF-5417 Drug Info Ki = 2340 nM [530752]
2-Amino-4,6-diphenyl-nicotinonitrile Drug Info Ki = 130 nM [529602]
1-Methyl-8-phenyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 2200 nM [526958]
LUF-5962 Drug Info Ki = 55 nM [528192]
Ethyl 5-benzoyl-4-phenylthiazol-2-ylcarbamate Drug Info Ki = 1640 nM [530752]
N-(4-Pyridin-2-yl-thiazol-2-yl)-benzamide Drug Info Ki = 8700 nM [526011]
Apadenoson Drug Info Ki = 0.5 nM [528068]
2,6-dphenyl-8-propyl-1-deazapurine Drug Info Ki = 114 nM [528673]
9-Isopropyl-9H-adenine Drug Info Ki = 4100 nM [530014]
CVT-6883 Drug Info Ki = 3280 nM [530243]
SCH 420814 Drug Info Ki = 0.6 nM [528627]
9-Cyclopentyl-9H-adenine Drug Info Ki = 1800 nM [530014]
N6-[(4-Amino)-phenyl]-9-benzyl-2-phenyladenine Drug Info Ki = 4170 nM [529183]
SCH-442416 Drug Info Ki = 0.5 nM [525917]
Caffeine Drug Info IC50 = 17 nM [552613]
2-(6-amino-8-bromo-9H-purin-9-yl)ethanol Drug Info Ki = 620 nM [530966]
2-(2-furyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine Drug Info Ki = 2.9 nM [529255]
4-(furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine Drug Info Ki = 242 nM [529858]
2-chloro-N6-cyclopentyladenosine Drug Info Ki = 2300 nM [529098]
ARISTEROMYCIN Drug Info Ki = 2150 nM [525783]
9-(4-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine Drug Info Ki = 372 nM [529421]
NECA Drug Info Ki = 22 nM [533449]
GALANGIN Drug Info Ki = 18100 nM [534439]
3-Benzyl-7-methyl-[1,8]naphthyridin-4-ol Drug Info Ki = 3330 nM [527683]
5-Azido-6-benzyl-2-methyl-[1,8]naphthyridine Drug Info Ki = 5360 nM [527683]
3-Benzyl-7-methyl-[1,8]naphthyridine-4-thiol Drug Info Ki = 9140 nM [527683]
SCH-63390 Drug Info Ki = 2.4 nM [534646]
1-Phenyl-3-(4-pyridin-2-yl-thiazol-2-yl)-urea Drug Info Ki = 920 nM [526011]
1H-Imidazo[4,5-c]quinolin-4-ylamine HCl Drug Info Ki = 1400 nM [530590]
LUF-5437 Drug Info Ki = 570 nM [526011]
1,3-Dibenzyl-3,7-dihydro-purine-2,6-dione Drug Info Ki = 14000 nM [533486]
N-(3-Phenyl-[1,2,4]thiadiazol-5-yl)-benzamide Drug Info Ki = 4400 nM [526011]
2-Amino-4,6-diphenyl-pyrimidine Drug Info Ki = 405 nM [529299]
N6-((+/-)-endo-norborn-2-yl)adenosine Drug Info Ki = 1270 nM [530035]
GNF-PF-2224 Drug Info Ki = 157 nM [530672]
(E,E)-8-(4-Phenylbutadien-1-yl)caffeine Drug Info Ki = 153 nM [529653]
(1H-Imidazo[4,5-c]quinolin-4-yl)-phenyl-amine HCl Drug Info Ki = 10500 nM [530590]
Phenyl(2-(trifluoromethyl)quinolin-4-yl)methanol Drug Info Ki = 9524 nM [529418]
6-(furan-2-yl)-9H-purin-2-amine Drug Info Ki = 261 nM [529858]
6-Furan-2-yl-9-phenethyl-9H-purin-2-ylamine Drug Info Ki = 270.5 nM [527503]
References
Ref 527823J Med Chem. 2005 Nov 3;48(22):6887-96.2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Ref 527040J Med Chem. 2004 Apr 22;47(9):2243-55.Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 530035J Med Chem. 2009 Apr 23;52(8):2393-406.N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 527933J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 529313J Med Chem. 2008 Mar 27;51(6):1764-70. Epub 2008 Feb 13.Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 529313J Med Chem. 2008 Mar 27;51(6):1764-70. Epub 2008 Feb 13.Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
Ref 527647J Med Chem. 2005 Jul 28;48(15):4910-8."Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Ref 552327Medicinal chemistry of A2A adenosine receptor antagonists. Curr Top Med Chem. 2003;3(4):403-11.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 531079J Med Chem. 2010 Sep 9;53(17):6386-97.Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
Ref 526958J Med Chem. 2004 Feb 12;47(4):1031-43.Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugswith peroral bioavailability.
Ref 530694Bioorg Med Chem Lett. 2010 Mar 1;20(5):1697-700. Epub 2010 Jan 20.Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists.
Ref 528434Bioorg Med Chem Lett. 2006 Dec 1;16(23):5993-7. Epub 2006 Sep 12.Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches.
Ref 530243J Med Chem. 2009 Jul 9;52(13):3994-4006.1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 530243J Med Chem. 2009 Jul 9;52(13):3994-4006.1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Ref 530966Eur J Med Chem. 2010 Aug;45(8):3459-71. Epub 2010 May 7.Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 529299Bioorg Med Chem. 2008 Mar 15;16(6):2741-52. Epub 2008 Jan 12.A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 529299Bioorg Med Chem. 2008 Mar 15;16(6):2741-52. Epub 2008 Jan 12.A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 530966Eur J Med Chem. 2010 Aug;45(8):3459-71. Epub 2010 May 7.Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 529305Bioorg Med Chem. 2008 Apr 1;16(7):3825-30. Epub 2008 Jan 30.Synthesis of eudistomin D analogues and its effects on adenosine receptors.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 529421Bioorg Med Chem Lett. 2008 May 1;18(9):2924-9. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidinesand 6-arylpurines.
Ref 533429J Med Chem. 1988 Oct;31(10):2034-9.Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists.
Ref 533429J Med Chem. 1988 Oct;31(10):2034-9.Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 533429J Med Chem. 1988 Oct;31(10):2034-9.Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 526104Bioorg Med Chem Lett. 2001 Jul 23;11(14):1931-4.Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor.
Ref 525578J Med Chem. 1999 Sep 9;42(18):3463-77.N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.
Ref 528969J Med Chem. 2007 Aug 23;50(17):4061-74. Epub 2007 Aug 1.New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Ref 530595Bioorg Med Chem Lett. 2010 Feb 1;20(3):1219-24. Epub 2009 Dec 1.Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonists.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528969J Med Chem. 2007 Aug 23;50(17):4061-74. Epub 2007 Aug 1.New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528969J Med Chem. 2007 Aug 23;50(17):4061-74. Epub 2007 Aug 1.New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 533955J Med Chem. 1993 Nov 12;36(23):3731-3.Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.
Ref 530590J Med Chem. 1991 Mar;34(3):1202-6.1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 529421Bioorg Med Chem Lett. 2008 May 1;18(9):2924-9. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidinesand 6-arylpurines.
Ref 530590J Med Chem. 1991 Mar;34(3):1202-6.1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.
Ref 527647J Med Chem. 2005 Jul 28;48(15):4910-8."Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Ref 529421Bioorg Med Chem Lett. 2008 May 1;18(9):2924-9. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidinesand 6-arylpurines.
Ref 527503Bioorg Med Chem Lett. 2005 Apr 15;15(8):2119-22.6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
Ref 528068Nat Rev Drug Discov. 2006 Mar;5(3):247-64.Adenosine receptors as therapeutic targets.
Ref 534583J Nat Prod. 1998 Feb;61(2):301-5.Bioactive pyridoacridine alkaloids from the micronesian sponge Oceanapia sp.
Ref 527717J Med Chem. 1992 Jun 12;35(12):2342-5.(E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 529653Bioorg Med Chem. 2008 Sep 15;16(18):8676-84. Epub 2008 Aug 5.Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues.
Ref 525562Bioorg Med Chem Lett. 1999 Jul 19;9(14):1979-84.Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist.
Ref 528752J Nat Prod. 2007 Apr;70(4):571-4. Epub 2007 Mar 24.Neuroprotective principles from Gastrodia elata.
Ref 527823J Med Chem. 2005 Nov 3;48(22):6887-96.2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 530243J Med Chem. 2009 Jul 9;52(13):3994-4006.1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Ref 529653Bioorg Med Chem. 2008 Sep 15;16(18):8676-84. Epub 2008 Aug 5.Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues.
Ref 528544J Med Chem. 2006 Nov 30;49(24):7119-31.Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.
Ref 530243J Med Chem. 2009 Jul 9;52(13):3994-4006.1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 527055Bioorg Med Chem Lett. 2004 May 17;14(10):2443-6.Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530966Eur J Med Chem. 2010 Aug;45(8):3459-71. Epub 2010 May 7.Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530590J Med Chem. 1991 Mar;34(3):1202-6.1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 526958J Med Chem. 2004 Feb 12;47(4):1031-43.Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugswith peroral bioavailability.
Ref 533429J Med Chem. 1988 Oct;31(10):2034-9.Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 529255J Med Chem. 2008 Feb 14;51(3):400-6. Epub 2008 Jan 12.Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 529653Bioorg Med Chem. 2008 Sep 15;16(18):8676-84. Epub 2008 Aug 5.Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues.
Ref 529299Bioorg Med Chem. 2008 Mar 15;16(6):2741-52. Epub 2008 Jan 12.A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 528684J Med Chem. 2007 Mar 22;50(6):1222-30. Epub 2007 Feb 20.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 529653Bioorg Med Chem. 2008 Sep 15;16(18):8676-84. Epub 2008 Aug 5.Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues.
Ref 527331J Med Chem. 2004 Dec 16;47(26):6529-40.2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 528434Bioorg Med Chem Lett. 2006 Dec 1;16(23):5993-7. Epub 2006 Sep 12.Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches.
Ref 529421Bioorg Med Chem Lett. 2008 May 1;18(9):2924-9. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidinesand 6-arylpurines.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 528748J Med Chem. 2007 Apr 19;50(8):1810-27. Epub 2007 Mar 23.Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 529183Eur J Med Chem. 2008 Aug;43(8):1639-47. Epub 2007 Oct 24.N6-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A adenosine receptors.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 529419Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 529421Bioorg Med Chem Lett. 2008 May 1;18(9):2924-9. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidinesand 6-arylpurines.
Ref 527647J Med Chem. 2005 Jul 28;48(15):4910-8."Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Ref 533394J Med Chem. 1985 Apr;28(4):487-92.1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
Ref 530372J Med Chem. 2009 Dec 10;52(23):7640-52.2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 529602J Med Chem. 2008 Aug 14;51(15):4449-55. Epub 2008 Jul 19.2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Ref 526958J Med Chem. 2004 Feb 12;47(4):1031-43.Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugswith peroral bioavailability.
Ref 528192J Med Chem. 2006 May 18;49(10):2861-7.2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
Ref 530752Bioorg Med Chem. 2010 Mar 15;18(6):2195-203. Epub 2010 Feb 4.2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Ref 526011J Med Chem. 2001 Mar 1;44(5):749-62.Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
Ref 528068Nat Rev Drug Discov. 2006 Mar;5(3):247-64.Adenosine receptors as therapeutic targets.
Ref 528673J Med Chem. 2007 Feb 22;50(4):828-34.2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 530243J Med Chem. 2009 Jul 9;52(13):3994-4006.1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Ref 528627Bioorg Med Chem Lett. 2007 Mar 1;17(5):1376-80. Epub 2006 Dec 3.Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
Ref 530014Bioorg Med Chem. 2009 Apr 1;17(7):2812-22. Epub 2009 Feb 23.8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Ref 529183Eur J Med Chem. 2008 Aug;43(8):1639-47. Epub 2007 Oct 24.N6-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A adenosine receptors.
Ref 525917J Med Chem. 2000 Nov 16;43(23):4359-62.Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography.
Ref 552613Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors. J Neurochem. 2006 Jul;98(2):616-28.
Ref 530966Eur J Med Chem. 2010 Aug;45(8):3459-71. Epub 2010 May 7.Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods.
Ref 529255J Med Chem. 2008 Feb 14;51(3):400-6. Epub 2008 Jan 12.Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy.
Ref 529858J Med Chem. 2009 Jan 8;52(1):33-47.Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Ref 529098Bioorg Med Chem. 2008 Jan 1;16(1):336-53. Epub 2007 Sep 22.5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivityfor A1 receptor from different species.
Ref 525783J Med Chem. 2000 Jun 1;43(11):2196-203.Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
Ref 529421Bioorg Med Chem Lett. 2008 May 1;18(9):2924-9. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidinesand 6-arylpurines.
Ref 533449J Med Chem. 1988 Jun;31(6):1179-83.Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives.
Ref 534439J Med Chem. 1997 Aug 1;40(16):2588-95.Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.
Ref 527683Bioorg Med Chem Lett. 2005 Oct 15;15(20):4604-10.1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors.
Ref 527683Bioorg Med Chem Lett. 2005 Oct 15;15(20):4604-10.1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors.
Ref 527683Bioorg Med Chem Lett. 2005 Oct 15;15(20):4604-10.1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors.
Ref 534646J Med Chem. 1998 Jun 4;41(12):2126-33.Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
Ref 526011J Med Chem. 2001 Mar 1;44(5):749-62.Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
Ref 530590J Med Chem. 1991 Mar;34(3):1202-6.1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.
Ref 526011J Med Chem. 2001 Mar 1;44(5):749-62.Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
Ref 533486J Med Chem. 1986 Jul;29(7):1305-8.Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Ref 526011J Med Chem. 2001 Mar 1;44(5):749-62.Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
Ref 529299Bioorg Med Chem. 2008 Mar 15;16(6):2741-52. Epub 2008 Jan 12.A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
Ref 530035J Med Chem. 2009 Apr 23;52(8):2393-406.N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
Ref 530672Eur J Med Chem. 2010 May;45(5):1739-45. Epub 2010 Jan 14.Synthesis and theoretical studies on energetics of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines--their potential as adenosine receptor ligands.
Ref 529653Bioorg Med Chem. 2008 Sep 15;16(18):8676-84. Epub 2008 Aug 5.Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues.
Ref 530590J Med Chem. 1991 Mar;34(3):1202-6.1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.
Ref 529418Bioorg Med Chem Lett. 2008 May 1;18(9):2916-9. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
Ref 529858J Med Chem. 2009 Jan 8;52(1):33-47.Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Ref 527503Bioorg Med Chem Lett. 2005 Apr 15;15(8):2119-22.6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.